FAST IMPACT Award (Innovative Methods to Advance Angelman Syndrome Treatments Towards Clinical Trials)
Funding Amount
Up to $1,000,000 per year
Deadline
Rolling
Grant Type
Foundation
Deadline history & next window
- Cycle
- Rolling — applications accepted year-round
- Tracked since
- April 2026
From the program guidelines: “Submission: Rolling basis with no set deadline”
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Other requirements
- Open to researchers presenting innovative ideas
- Researchers with exciting proof-of-concept work
- Application Process: Rolling basis - there is no deadline.
- All grant applications are considered on a rolling basis.
Overview
FAST IMPACT Award
The FAST IMPACT (Innovative Methods to Advance Angelman Syndrome Treatments Towards Clinical Trials) Award provides substantial support for comprehensive, translational research platform projects, spanning from pre-clinical research to human candidate drugs, which can then be advanced to the stage where Investigational New Drug (IND) application preparation is enabled.
Award Structure: Multi-year funding
Geographic Scope: International
Focus Areas:
- Comprehensive translational research platforms
- Pre-clinical research through human candidate drugs
- IND application preparation enablement
- Innovative ideas
- Exciting proof-of-concept work
- Advancing therapeutic opportunities to humans living with Angelman syndrome
Eligibility:
- Open to researchers presenting innovative ideas
- Researchers with exciting proof-of-concept work
Application Process: Rolling basis - there is no deadline. All grant applications are considered on a rolling basis.
How to Apply
Application Process
Submission: Rolling basis with no set deadline
Contact for Questions or Application Details:
- Email: science@cureangelman.org
- Applications and more information available at the grant application page on the website
What Foundation for Angelman Syndrome Therapeutics actually gave
Source: IRS Form 990, 2024
- Grants in 2024
- 10
- Total given
- $7.92M
- Median grant
- $242K
- Range
- $51K–$5.86M
- By dollars: Pennsylvania 74%, California 8%, Massachusetts 6%. Top recipient cities: Providence, RI; Philadelphia, PA; Boston, MA.
- 0% of grants with a stated purpose were for general or operating support.
Example grants
University of Pennsylvania · Philadelphia, PA
Upenn 2023: research, collaboration & license agreement
$5.86M
Boston Children's Hospital · Boston, MA
Ft2022-006: abom - natural history study
$471K
Rush University Medical Center · Chicago, IL
Rush coe
$321K
Duke University · Charlotte, NC
Ft2018-005 amended: gpic-comm
$318K
Regents of the University of California Davis · Davis, CA
Ft2022-007: gastrointestinal biomarkers in preclinical models of angelman syndrome
$274K
Focus Areas & Funding Uses
Fields of Work
- Science research
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
FAST Postdoctoral Fellowship
Foundation for Angelman Syndrome Therapeutics
Amount
Up to $50,000 per year for up to two years
Deadline
Rolling
FAST-TRAC Award (Targeted Research to Advance a Cure)
Foundation for Angelman Syndrome Therapeutics
Amount
Up to $150,000 per year
Deadline
Rolling
FAST Innovation Seed Grant
Foundation for Angelman Syndrome Therapeutics
Amount
$10,000 - $50,000
Deadline
Rolling
New Investigator Award
Foundation for Angelman Syndrome Therapeutics
Amount
Up to $150,000 per year
Deadline
Rolling
CLL Global Research Foundation Research Grant
CLL Global Research Foundation
Amount
Up to $150K
Deadline
Deadline not published
Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)
National Institutes of Health
Amount
Up to $50,000
Deadline
October 19, 2026
Ready to apply for FAST IMPACT Award (Innovative Methods to Advance Angelman Syndrome Treatments Towards Clinical Trials)?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found FAST IMPACT Award (Innovative Methods to Advance Angelman Syndrome Treatments Towards Clinical Trials). Now let's win it.